Perimeter Medical Imaging AI to Participate in Investor Conference
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) is excited to announce its participation in a notable healthcare investor conference. This prestigious event allows the company to showcase its progress and developments in the medical technology field, particularly in advanced imaging tools that aim to enhance cancer surgery outcomes.
Details of the Conference Presentation
Management will present a comprehensive update on the company's innovative projects at the 2025 Bloom Burton & Co. Healthcare Investor Conference. This significant presentation will take place on Monday at the Metro Toronto Convention Centre, offering insights into the company's vision and future developments.
Virtual Access to the Presentation
For those unable to attend in person, the presentation will also be broadcast live, ensuring wider accessibility. Interested participants can find the live stream on Perimeter's website under the "News/Events" section. This move highlights the company's commitment to transparency and open communication with its stakeholders.
About Perimeter Medical Imaging AI
Headquartered in major cities, Perimeter Medical Imaging AI is dedicated to transforming the surgical landscape with revolutionary imaging technology. The company's flagship FDA-cleared Perimeter S-Series OCT system allows for real-time visualization of excised tissues, providing surgeons with crucial insights at the cellular level.
Innovations in Cancer Imaging
In addition to the S-Series, Perimeter is advancing its next-generation artificial intelligence technology through the Perimeter B-Series OCT with ImgAssist AI. This system has recently been involved in pivotal clinical trials, supported by significant funding aimed at enhancing cancer detection and surgical outcomes.
Commitment to Quality and Compliance
While the B-Series OCT is currently limited to investigational use, it represents a promising step towards redefining cancer surgery. The S-Series system, on the other hand, has been proven safe for general use, encompassing various indications. It is important to note that while these advancements are groundbreaking, the effectiveness of the uses for breast cancer and other types hasn’t yet been fully established.
Looking to the Future
Perimeter continually evaluates its business strategies and clinical testing outcomes to ensure they operate in alignment with industry regulations and standards. With a vision that incorporates rigorous scientific evaluation, Perimeter aims to pave the way for innovative solutions that meet high unmet medical needs.
CONTACTS
Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Frequently Asked Questions
What is Perimeter Medical Imaging AI?
Perimeter Medical Imaging AI, Inc. is a medical technology company focused on enhancing surgical procedures through advanced imaging systems.
When is Perimeter's presentation scheduled?
The presentation is scheduled for a Monday at the Metro Toronto Convention Centre.
How can I access the presentation?
The presentation will be live-streamed on Perimeter’s website, offering accessibility to all interested parties.
What is the Perimeter S-Series OCT?
The Perimeter S-Series OCT system is an FDA-cleared imaging tool providing real-time visualization of excised tissues at a cellular level.
What innovations is Perimeter pursuing?
Perimeter is actively developing its next-generation imaging technology, the Perimeter B-Series OCT with ImgAssist AI, which is currently under clinical evaluation.
